- Report
- March 2025
- 191 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- April 2024
- 402 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- January 2024
- 213 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- February 2024
- 202 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- October 2022
- 194 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- November 2020
- 217 Pages
Global
From €3803EUR$4,000USD£3,195GBP
- Report
- August 2023
- 370 Pages
Global
From €2367EUR$2,490USD£1,989GBP
- Report
- February 2024
- 90 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- July 2024
- 326 Pages
China
From €3803EUR$4,000USD£3,195GBP
- Report
- July 2024
- 187 Pages
China
From €1711EUR$1,800USD£1,438GBP
- Report
- September 2023
- 114 Pages
Global
From €2804EUR$2,950USD£2,356GBP
- Report
- September 2023
- 87 Pages
Africa, Middle East
From €2804EUR$2,950USD£2,356GBP
- Report
- September 2023
- 112 Pages
Europe
From €3280EUR$3,450USD£2,755GBP
- Report
- September 2023
- 194 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- July 2020
- 213 Pages
Global, China
From €3042EUR$3,200USD£2,556GBP
- Report
- November 2023
- 112 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- October 2023
- 87 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- April 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- April 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
The Poliomyelitis Vaccine market is a subset of the larger Vaccines market. Poliomyelitis Vaccines are used to prevent the spread of the poliovirus, a highly contagious virus that can cause paralysis and even death. The World Health Organization (WHO) recommends that all children receive the Poliomyelitis Vaccine as part of their routine immunization schedule. The Poliomyelitis Vaccine market is composed of a variety of products, including inactivated and live attenuated vaccines. Inactivated vaccines are made from killed poliovirus, while live attenuated vaccines are made from weakened poliovirus.
The Poliomyelitis Vaccine market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Emergent BioSolutions. Show Less Read more
